Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1993 | 1 |
2009 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
4,4'-Diacetyl curcumin--in-vitro histamine-blocking activity.
J Pharm Pharmacol. 1993 Aug;45(8):766. doi: 10.1111/j.2042-7158.1993.tb07109.x.
J Pharm Pharmacol. 1993.
PMID: 7901380
No abstract available.
Identification of curcumin derivatives as human LMTK3 inhibitors for breast cancer: a docking, dynamics, and MM/PBSA approach.
Anbarasu K, Jayanthi S.
Anbarasu K, et al.
3 Biotech. 2018 May;8(5):228. doi: 10.1007/s13205-018-1239-6. Epub 2018 Apr 27.
3 Biotech. 2018.
PMID: 29719770
Free PMC article.
From our study, novel LMTK3 inhibitors tetrahydrocurcumin, curcumin 4,4'-diacetate, and demethoxycurcumin have been proposed with inhibition mechanism. ...
From our study, novel LMTK3 inhibitors tetrahydrocurcumin, curcumin 4,4'-diacetate, and demethoxycurcumin have b …
Item in Clipboard
Curcumin derivatives: molecular basis of their anti-cancer activity.
Basile V, Ferrari E, Lazzari S, Belluti S, Pignedoli F, Imbriano C.
Basile V, et al.
Biochem Pharmacol. 2009 Nov 15;78(10):1305-15. doi: 10.1016/j.bcp.2009.06.105. Epub 2009 Jul 4.
Biochem Pharmacol. 2009.
PMID: 19580791
Item in Clipboard
Cite
Cite